Congrats all! Stock on it way to $100🚀
The system is an all-in-one, high-density mapping and pulsed field and radiofrequency ablation catheter for treatment of persistent atrial fibrillation, or AFib, and for radiofrequency ablation of cavotricuspid isthmus dependent atrial flutter, the company said.
Medtronic (MDT) said the approval makes it the only company with two pulsed field ablation, or PFA, technologies available for patients with AFib.
The FDA approved Medtronic’s (MDT) PulseSelect Pulsed Field Ablation System in December 2023.